Mirjana Efremova

18.7k citations

21 papers · 6.4k indexed · 2 hit papers · h-index 14

Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 5
Immunology top 1%
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 3
Oncology top 1%
- Cancer Immunotherapy and Biomarkers 6
- Cancer Cells and Metastasis 3
Pulmonary and Respiratory Medicine top 1%
Molecular Biology top 2%
- Single-cell and spatial transcriptomics 9
- Gene Regulatory Network Analysis 2

Co-authors: Sarah A. Teichmann Zlatko Trajanoski Roser Vento‐Tormo Dietmar Rieder Francesca Finotello Hubert Hackl Pornpimol Charoentong Mihaela Angelova
Cited by: Cancer Research Immunology Oncology
Partner nations: United Kingdom Austria United States

In The Last Decade

Mirjana Efremova

19 papers receiving 6.3k citations

Hit Papers

align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2020 CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexes
2017 Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade

Peers

Countries citing papers authored by Mirjana Efremova

Since Specialization

Citations

This map shows the geographic impact of Mirjana Efremova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mirjana Efremova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mirjana Efremova more than expected).

Fields of papers citing papers by Mirjana Efremova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mirjana Efremova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mirjana Efremova. The network helps show where Mirjana Efremova may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Mirjana Efremova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mirjana Efremova Line = papers co-authored together Mirjana Efremova links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Phenotypic heterogeneity and plasticity in colorectal cancer metastasis Samuel Ogden,Nasrine Metic,Ozen Leylek,Elise Smith,Alison Berner,Ann‐Marie Baker,Imran Uddin,Marta Buzzetti,Marco Gerlinger,Trevor A. Graham,Hemant M. Kocher,Mirjana Efremova	2025	3
2	Various cell types in tissues cooperate in networks that are disrupted in disease Mirjana Efremova	2025	0
3	Tissue-resident memory T cells in epicardial adipose tissue comprise transcriptionally distinct subsets that are modulated in atrial fibrillation Vishal Vyas,Balraj Sandhar,Jack M. Keane,Elizabeth G. Wood,Hazel Blythe,Aled Jones,Eriomina Shahaj,Silvia Fanti,Jack Williams,Nasrine Metic,Mirjana Efremova,Han Leng Ng,Gayathri Nageswaran,Suzanne Byrne,Niklas Feldhahn,Federica M. Marelli‐Berg,Benny Chain,Andrew Tinker,Malcolm Finlay,M. Paula Longhi	2024	12
4	scMoMaT jointly performs single cell mosaic integration and multi-modal bio-marker detection Ziqi Zhang,Haoran Sun,Ragunathan Mariappan,Xi Chen,Xinyu Chen,Mika Sarkin Jain,Mirjana Efremova,Sarah A. Teichmann,Vaibhav Rajan,Xiuwei Zhang	2023	22
5	Longitudinal Single Cell Analyses Reveal the Co-Evolutionary Dynamics of the Tumor and Microenvironment Accompanying Follicular Lymphoma Transformation Megan Perrett,Lucy Pickard,Emil Kumar,Giuseppe Palladino,Faraz Khan,Carina Edmondson,Connor H. Knight,Edward Poynton,Janet Matthews,Shamzah Araf,Andrew Clear,Maria Calaminici,John G. Gribben,Hamish W. King,Mirjana Efremova,Jun Wang,Jessica Okosun	2022	1
6	Inference of Ligand–Receptor Pairs from Single-Cell Transcriptomics Data Mirjana Efremova,Roser Vento‐Tormo	2021	2
7	MultiMAP: dimensionality reduction and integration of multimodal data Mika Sarkin Jain,Krzysztof Polański,Cecilia Domínguez Conde,Xi Chen,Jong-Eun Park,Lira Mamanova,Andrew Knights,Rachel A. Botting,Emily Stephenson,Muzlifah Haniffa,Austen Lamacraft,Mirjana Efremova,Sarah A. Teichmann	2021	44
8	Mosquito cellular immunity at single-cell resolution Gianmarco Raddi,Ana Beatriz F. Barletta,Mirjana Efremova,José L. Ramírez,Rafael Cantera,Sarah A. Teichmann,Carolina Barillas‐Mury,Oliver Billker	2020	80
9	Computational methods for single-cell omics across modalities Mirjana Efremova,Sarah A. Teichmann	2020	124
10	CellPhoneDB: inferring cell–cell communication from combined expression of multi-subunit ligand–receptor complexesbreakdown → Mirjana Efremova,Miquel Vento-Tormo,Sarah A. Teichmann,Roser Vento‐Tormo	2020	1792
11	Single-Cell RNA Sequencing Reveals a Dynamic Stromal Niche That Supports Tumor Growth Sarah Davidson,Mirjana Efremova,Angela Riedel,Bidesh Mahata,Jhuma Pramanik,Jani Huuhtanen,Gozde Kar,Roser Vento‐Tormo,Tzachi Hagai,Xi Chen,Muzlifah Haniffa,Jacqueline D. Shields,Sarah A. Teichmann	2020	205
12	Immunology in the Era of Single-Cell Technologies Mirjana Efremova,Roser Vento‐Tormo,Jong-Eun Park,Sarah A. Teichmann,Kylie R. James	2020	51
13	Abstract A102: Rescue of lost skin dendritic cells in melanoma is key for the resuscitation of antitumor T-cell responses Anastasia Prokopi,Christoph H. Tripp,Bart Tummers,Kerstin Komenda,Katharina Hutter,Giuseppe Cappellano,Lydia Bellmann,Mirjana Efremova,Zlatko Trajanoski,Suzie Chen,Björn E. Clausen,Douglas R. Green,Patrizia Stoitzner	2019	1
14	Nuclear receptor NR2F6 inhibition potentiates responses to PD-L1/PD-1 cancer immune checkpoint blockade Victoria Klepsch,Natascha Hermann‐Kleiter,Patricia Do-Dinh,Bojana Jakic,Anne Offermann,Mirjana Efremova,Sieghart Sopper,Dietmar Rieder,Anne Krogsdam,Gabriele Gamerith,Sven Perner,Alexandar Tzankov,Zlatko Trajanoski,Dominik Wolf‎,Gottfried Baier	2018	52
15	Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution Mirjana Efremova,Dietmar Rieder,Victoria Klepsch,Pornpimol Charoentong,Francesca Finotello,Hubert Hackl,Natascha Hermann‐Kleiter,Martin Löwer,Gottfried Baier,Anne Krogsdam,Zlatko Trajanoski	2017	188
16	Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy Mirjana Efremova,Francesca Finotello,Dietmar Rieder,Zlatko Trajanoski	2017	151
17	Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockadebreakdown → Pornpimol Charoentong,Francesca Finotello,Mihaela Angelova,Clemens Mayer,Mirjana Efremova,Dietmar Rieder,Hubert Hackl,Zlatko Trajanoski	2017	3188
18	A survey of tools for variant analysis of next-generation genome sequencing data Stephan Pabinger,Andreas Dander,M. Fischer,René Snajder,Michael Sperk,Mirjana Efremova,Birgit Krabichler,Michael R. Speicher,Johannes Zschocke,Zlatko Trajanoski	2013	394
19	Mathematical models for translational and clinical oncology Ralf Gallasch,Mirjana Efremova,Pornpimol Charoentong,Hubert Hackl,Zlatko Trajanoski	2013	15
20	Bioinformatics for cancer immunology and immunotherapy Pornpimol Charoentong,Mihaela Angelova,Mirjana Efremova,Ralf Gallasch,Hubert Hackl,Jérôme Galon,Zlatko Trajanoski	2012	36

About Mirjana Efremova

Mirjana Efremova is a scholar working on Immunology, Biophysics and Cancer Research, having authored 21 papers that have together received 6.4k indexed citations. Recurring topics across this work include Single-cell and spatial transcriptomics (9 papers), Cancer Immunotherapy and Biomarkers (6 papers), Cancer Genomics and Diagnostics (5 papers), T-cell and B-cell Immunology (5 papers), Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (3 papers), Cancer Cells and Metastasis (3 papers) and Gene Regulatory Network Analysis (2 papers). The work is most often cited by research in Cancer Research (1.7k citations), Immunology (2.1k citations) and Oncology (2.3k citations). Mirjana Efremova has collaborated with scholars based in United Kingdom, Austria and United States. Frequent co-authors include Sarah A. Teichmann, Zlatko Trajanoski, Roser Vento‐Tormo, Dietmar Rieder, Francesca Finotello, Hubert Hackl, Pornpimol Charoentong, Mihaela Angelova, Clemens Mayer and Stephan Pabinger.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact